Story perspectives

FDA Set to Lift Injectable Peptide Restrictions Amid Concerns

4/1/2026

Summary

Story summary

The FDA is reportedly preparing to lift restrictions on injectable peptides after Health Secretary Robert F. Kennedy Jr.'s advocacy on Joe Rogan Experience.
The reversal could allow compounding pharmacies to produce peptides previously banned for safety concerns.
Experts warn that this move may undermine the drug approval process and normalize unproven treatments.
Public health officials caution risks and lack of rigorous testing, while Kennedy argues many peptides are safe.

1 of 1

Story summary

The FDA is reportedly preparing to lift restrictions on injectable peptides after Health Secretary Robert F. Kennedy Jr.'s advocacy on Joe Rogan Experience.
The reversal could allow compounding pharmacies to produce peptides previously banned for safety concerns.
Experts warn that this move may undermine the drug approval process and normalize unproven treatments.
Public health officials caution risks and lack of rigorous testing, while Kennedy argues many peptides are safe.